 |
Esmon CT.
Regulation of blood coagulation. Biochimica et Biophysica Acta. 1477(1-2):349-60, 2000.
|
 |
 |
Levi M. Ten Cate H.
Disseminated intravascular coagulation. New England Journal of Medicine. 341(8):586-92, 1999.
|
 |
 |
Bick RL. Arun B. Frenkel EP.
Disseminated intravascular coagulation. clinical and pathophysiological mechanisms and manifestations. Haemostasis. 29(2-3):111-34, 1999.
|
 |
 |
May AE. Neumann FJ. Preissner KT.
The relevance of blood cell-vessel wall adhesive interactions for vascular thrombotic disease. Thrombosis & Haemostasis. 82(2):962-70, 1999.
|
 |
 |
Lockwood CJ.
Heritable coagulopathies in pregnancy. Obstetrical & Gynecological Survey. 54(12):754-65, 1999.
|
 |
 |
Deutsch E.
The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory. American Heart Journal. 138(6 Pt 2):S577-85, 1999.
|
 |
 |
Peyvandi F. Mannucci PM.
Rare coagulation disorders. Thrombosis & Haemostasis. 82(4):1207-14, 1999.
|
 |
 |
de Gaetano G. Cerletti C. Evangelista V.
Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis. 29(1):41-9, 1999.
|
 |
 |
Despotis GJ. Joist JH.
Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Journal of Cardiothoracic & Vascular Anesthesia. 13(4 Suppl 1):18-29; discussion 36-7, 1999.
|
 |
 |
Esmon CT. Fukudome K. Mather T. Bode W. Regan LM. Stearns-Kurosawa DJ. Kurosawa S.
Inflammation, sepsis, and coagulation. Haematologica. 84(3):254-9, 1999.
|
 |
 |
Esmon CT. Gu JM. Xu J. Qu D. Stearns-Kurosawa DJ. Kurosawa S.
Regulation and functions of the protein C anticoagulant pathway. Haematologica. 84(4):363-8, 1999.
|
 |
 |
Lip GY. Gibbs CR.
Does heart failure confer a hypercoagulable state? Virchow's triad revisited. Journal of the American College of Cardiology. 33(5):1424-6, 1999.
|
 |
 |
Bajaj SP. Joist JH.
New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy. Seminars in Thrombosis & Hemostasis. 25(4):407-18, 1999.
|
 |
 |
Blauhut B.
Indications for prothrombin complex concentrates in massive transfusions. Thrombosis Research. 95(4 Suppl 1):S63-9, 1999.
|
 |
 |
Narayanan S.
Multifunctional roles of thrombin. Annals of Clinical & Laboratory Science. 29(4):275-80, 1999.
|
 |
 |
Risberg B.
Antithrombin: facts and new hypotheses. Blood Coagulation & Fibrinolysis. 9 Suppl 3:S3-6, 1998.
|
 |
 |
Nielsen JD.
The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis. 9 Suppl 3:S11-5, 1998.
|
 |
 |
Gordjani N. Sutor AH.
Coagulation changes associated with the hemolytic uremic syndrome. Seminars in Thrombosis & Hemostasis. 24(6):577-82, 1998.
|
 |
 |
Markland FS.
Snake venoms and the hemostatic system. Toxicon. 36(12):1749-800, 1998.
|
 |
 |
Mann KG. van't Veer C. Cawthern K. Butenas S.
The role of the tissue factor pathway in initiation of coagulation. Blood Coagulation & Fibrinolysis. 9 Suppl 1:S3-7, 1998.
|
 |
 |
de Jonge E. Levi M. Stoutenbeek CP. van Deventer SJ.
Current drug treatment strategies for disseminated intravascular coagulation. Drugs. 55(6):767-77, 1998.
|
 |
 |
Cicala C. Cirino G.
Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sciences. 62(20):1817-24, 1998.
|
 |
 |
Okajima K. Uchiba M.
The anti-inflammatory properties of antithrombin III: new therapeutic implications. Seminars in Thrombosis & Hemostasis. 24(1):27-32, 1998.
|
 |
 |
Mammen EF.
The haematological manifestations of sepsis. Journal of Antimicrobial Chemotherapy. 41 Suppl A:17-24, 1998.
|
 |
 |
Bell WR Jr.
Defibrinogenating enzymes. Drugs. 54 Suppl 3:18-30; discussion 30-1, 1997.
|
 |
 |
Markland FS Jr.
Snake venoms. Drugs. 54 Suppl 3:1-10, 1997.
|
 |
 |
van Boven HH. Lane DA.
Antithrombin and its inherited deficiency states. Seminars in Hematology. 34(3):188-204, 1997.
|
 |
 |
Levi M. van der Poll T. ten Cate H. van Deventer SJ.
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. European Journal of Clinical Investigation. 27(1):3-9, 1997.
|
 |